BofA Raises Eli Lilly Price Target to $1,497, Maintains Buy Rating
Bank of America raised its price target on Eli Lilly to $1,497 from $1,397 while maintaining a Buy rating. The move followed stronger-than-expected third-quarter results.
Bank of America raised its price target on Eli Lilly to $1,497 from $1,397 while maintaining a Buy rating. The move followed stronger-than-expected third-quarter results.